XML 86 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 1,160,092 $ 438,915 $ 918,305
Adjustments to reconcile net income to net cash used in operating activities:      
Net cash used in operating activities (233,261) (734,112) (2,596,045)
Cash flows from investing activities:      
Net cash used in investing activities (111,079) (337,379) (1,084,633)
Allocable to redeemable and non-controlling interests in Consolidated Funds:      
Net cash provided by financing activities 292,126 1,128,063 3,503,625
Effect of exchange rate changes 10,501 (10,240) (19,104)
Net change in cash and cash equivalents (41,713) 46,332 (196,157)
Cash and cash equivalents, beginning of period 389,987 343,655  
Cash and cash equivalents, end of period 348,274 389,987 343,655
Supplemental disclosure of non-cash financing activities:      
Issuance of AOG Units and Class A common stock in connection with acquisition-related activities 239,545 12,835 510,848
Issuance of AOG Units in connection with settlement of management incentive program 245,647 0 0
Cash paid during the period for interest 722,643 320,329  
Cash paid during the period for income taxes 62,007 104,864  
Consolidated Funds       
Adjustments to reconcile net income to net cash used in operating activities:      
Net realized and unrealized (gains) losses on investments (262,700) (73,386) (77,303)
Other (income) expense, net (101,465) (33,822) (35,879)
Investments purchased (8,847,856) (9,434,029) (13,067,564)
Proceeds from sale of investments 8,149,617 8,198,812 9,970,609
Change in cash and cash equivalents held at Consolidated Funds (424,870) 324,550 (526,815)
Net cash relinquished with consolidation/deconsolidation of Consolidated Funds (623) 0 (39,539)
Change in other assets and receivables held at Consolidated Funds (20,247) 151,895 (180,953)
Change in other liabilities and payables held at Consolidated Funds 219,046 (733,417) 723,616
Cash flows from investing activities:      
Acquisitions, net of cash acquired     (1,057,407)
Allocable to redeemable and non-controlling interests in Consolidated Funds:      
Contributions from redeemable and non-controlling interests in Consolidated Funds 855,456 549,396 1,033,644
Distributions to non-controlling interests in Consolidated Funds (101,128) (178,291) (98,897)
Redemptions of redeemable interests in Consolidated Funds (1,045,874) 0 0
Borrowings under loan obligations by Consolidated Funds 1,387,297 1,140,680 2,048,932
Repayments under loan obligations by Consolidated Funds (398,864) (145,222) (80,752)
Ares Management L.P      
Adjustments to reconcile net income to net cash used in operating activities:      
Equity compensation expense 255,965 200,391 237,191
Depreciation and amortization 231,712 341,341 113,293
Net realized and unrealized (gains) losses on investments (90,737) 10,929 (88,978)
Other (income) expense, net 74 0 (31,070)
Investments purchased (507,932) (371,124) (340,199)
Proceeds from sale of investments 206,163 182,493 273,382
Net carried interest and incentive fees receivable (48,858) (20,612) (745,021)
Due to/from affiliates (220,421) 39,073 (180,928)
Other assets 21,532 (105,205) 213,825
Accrued compensation and benefits 20,383 200,769 142,815
Accounts payable, accrued expenses and other liabilities 27,864 (51,685) 125,168
Cash flows from investing activities:      
Purchase of furniture, equipment and leasehold improvements, net of disposals (67,183) (35,796) (27,226)
Acquisitions, net of cash acquired (43,896) (301,583) (1,057,407)
Cash flows from financing activities:      
Net proceeds from issuance of Class A and non-voting common stock 0 0 827,430
Proceeds from Credit Facility 1,410,000 1,380,000 883,000
Proceeds from issuance of senior and subordinated notes 499,010 488,915 450,000
Repayments of Credit Facility (1,215,000) (1,095,000) (468,000)
Dividends and distributions  (1,030,666) (836,364) (593,506)
Series A Preferred Stock dividends 0 0 (10,850)
Redemption of Series A Preferred Stock 0 0 (310,000)
Stock option exercises 85,959 21,205 37,216
Taxes paid related to net share settlement of equity awards (157,007) (201,311) (226,101)
Other financing activities 2,943 4,055 11,509
Allocable to redeemable and non-controlling interests in Consolidated Funds:      
Cash and cash equivalents, beginning of period 389,987 343,655 539,812
Cash and cash equivalents, end of period $ 348,274 389,987 343,655
Supplemental disclosure of non-cash financing activities:      
Cash paid during the period for interest   320,329 205,085
Cash paid during the period for income taxes   $ 104,864 $ 22,788